Inhibition of the tonic contraction in the treatment of erectile dysfunction

Liming Jin, A. Elizabeth Linder, Thomas M. Mills, R Clinton Webb

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Erectile dysfunction (ED) reduces the quality of life. It is estimated that 52% of men have some degree of ED, which is associated with ageing. While it is clear that there are a variety of current treatment options for ED, each of these has drawbacks and contraindications. A better understanding of the physiological mechanisms involved in penile erection will provide new ways to treat ED. This review not only focuses on the vasoconstrictors and vasodilators that control the state of contraction and relaxation of the corpora cavernosa smooth muscle, but also presents a novel Ca2+-sensitising pathway that contributes to maintaining the penis in the non-erect state. Studies have shown that inhibition of the RhoA/Rho-kinase signalling pathway induces penile erection. Further understanding of this RhoA/Rho-kinase pathway may provide a novel alternative treatment for ED.

Original languageEnglish (US)
Pages (from-to)265-276
Number of pages12
JournalExpert Opinion on Therapeutic Targets
Volume7
Issue number2
DOIs
StatePublished - Apr 1 2003

Fingerprint

rho-Associated Kinases
Erectile Dysfunction
Vasoconstrictor Agents
Penile Erection
Vasodilator Agents
Muscle
Aging of materials
Therapeutics
Penis
Smooth Muscle
Quality of Life
Inhibition (Psychology)

Keywords

  • Erectile dysfunction
  • Rho-kinase
  • RhoA

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Inhibition of the tonic contraction in the treatment of erectile dysfunction. / Jin, Liming; Linder, A. Elizabeth; Mills, Thomas M.; Webb, R Clinton.

In: Expert Opinion on Therapeutic Targets, Vol. 7, No. 2, 01.04.2003, p. 265-276.

Research output: Contribution to journalReview article

Jin, Liming ; Linder, A. Elizabeth ; Mills, Thomas M. ; Webb, R Clinton. / Inhibition of the tonic contraction in the treatment of erectile dysfunction. In: Expert Opinion on Therapeutic Targets. 2003 ; Vol. 7, No. 2. pp. 265-276.
@article{bd5bd7378a514046bf565b82b1dd359b,
title = "Inhibition of the tonic contraction in the treatment of erectile dysfunction",
abstract = "Erectile dysfunction (ED) reduces the quality of life. It is estimated that 52{\%} of men have some degree of ED, which is associated with ageing. While it is clear that there are a variety of current treatment options for ED, each of these has drawbacks and contraindications. A better understanding of the physiological mechanisms involved in penile erection will provide new ways to treat ED. This review not only focuses on the vasoconstrictors and vasodilators that control the state of contraction and relaxation of the corpora cavernosa smooth muscle, but also presents a novel Ca2+-sensitising pathway that contributes to maintaining the penis in the non-erect state. Studies have shown that inhibition of the RhoA/Rho-kinase signalling pathway induces penile erection. Further understanding of this RhoA/Rho-kinase pathway may provide a novel alternative treatment for ED.",
keywords = "Erectile dysfunction, Rho-kinase, RhoA",
author = "Liming Jin and Linder, {A. Elizabeth} and Mills, {Thomas M.} and Webb, {R Clinton}",
year = "2003",
month = "4",
day = "1",
doi = "10.1517/14728222.7.2.265",
language = "English (US)",
volume = "7",
pages = "265--276",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Inhibition of the tonic contraction in the treatment of erectile dysfunction

AU - Jin, Liming

AU - Linder, A. Elizabeth

AU - Mills, Thomas M.

AU - Webb, R Clinton

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Erectile dysfunction (ED) reduces the quality of life. It is estimated that 52% of men have some degree of ED, which is associated with ageing. While it is clear that there are a variety of current treatment options for ED, each of these has drawbacks and contraindications. A better understanding of the physiological mechanisms involved in penile erection will provide new ways to treat ED. This review not only focuses on the vasoconstrictors and vasodilators that control the state of contraction and relaxation of the corpora cavernosa smooth muscle, but also presents a novel Ca2+-sensitising pathway that contributes to maintaining the penis in the non-erect state. Studies have shown that inhibition of the RhoA/Rho-kinase signalling pathway induces penile erection. Further understanding of this RhoA/Rho-kinase pathway may provide a novel alternative treatment for ED.

AB - Erectile dysfunction (ED) reduces the quality of life. It is estimated that 52% of men have some degree of ED, which is associated with ageing. While it is clear that there are a variety of current treatment options for ED, each of these has drawbacks and contraindications. A better understanding of the physiological mechanisms involved in penile erection will provide new ways to treat ED. This review not only focuses on the vasoconstrictors and vasodilators that control the state of contraction and relaxation of the corpora cavernosa smooth muscle, but also presents a novel Ca2+-sensitising pathway that contributes to maintaining the penis in the non-erect state. Studies have shown that inhibition of the RhoA/Rho-kinase signalling pathway induces penile erection. Further understanding of this RhoA/Rho-kinase pathway may provide a novel alternative treatment for ED.

KW - Erectile dysfunction

KW - Rho-kinase

KW - RhoA

UR - http://www.scopus.com/inward/record.url?scp=0037397573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037397573&partnerID=8YFLogxK

U2 - 10.1517/14728222.7.2.265

DO - 10.1517/14728222.7.2.265

M3 - Review article

C2 - 12667102

AN - SCOPUS:0037397573

VL - 7

SP - 265

EP - 276

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 2

ER -